NAKIA MURPHY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SMYRNA, GA NPI 1316788367
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GA Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$731.07
- Category: General Payments
- Program years: PY2024
- Record count: 30
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $731.07 across 30 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $731.07 | 30 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $104.42 | 4 |
| SOBI, INC | $75.30 | 3 |
| GENZYME CORPORATION | $57.21 | 2 |
| Alexion Pharmaceuticals, Inc. | $47.69 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $47.46 | 2 |
| Rigel Pharmaceuticals, Inc. | $44.70 | 2 |
| Lilly USA, LLC | $42.29 | 2 |
| Merck Sharp & Dohme Corporation | $31.02 | 1 |
| JAZZ PHARMACEUTICALS INC. | $29.15 | 1 |
| GlaxoSmithKline, LLC. | $29.02 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.93 | 1 |
| Regeneron Healthcare Solutions, Inc. | $27.85 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.76 | 1 |
| EMD Serono, Inc. | $25.95 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.02 | 1 |
| ADC Therapeutics America, Inc. | $22.46 | 1 |
| Janssen Biotech, Inc. | $17.87 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.28 | 1 |
| Legend Biotech USA Inc. | $16.31 | 1 |
| Acrotech Biopharma Inc. | $14.38 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $731.07 | 30 |
Records — PY2024 (30)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.